Influence of different statins on the ability Clopidogrel to inhibit platelet aggregation in patients with unstable angina
Mahmoud Mohamad Shehata;
Abstract
For many years, unstable angina has been considered as an" intermediate syndrome" between chronic stable angina and acute myocardial infarction.
In recent years, its physiopathology has been clarified and there have been major advances in management.
Pathological, angioscopic and biological observations have demonstrated that unstable angina and myocardial infarction are different clinical presentations that result from a common underlying pathophysiological mechanism, namely, atherosclerotic plaque rupture or erosion, with differing degrees of superimposed thrombosis and distal embolization.
Clopidogrel inhibits platelet aggregation through binding selectively and noncompetitively to platelet ADP receptor in an irreversible manner preventing activation of glycoprotein lib/lila receptor which mediates the final common pathway of platelet aggregation.
Atorvastatin is a (HMG-CoA) reductase inhibitor widely used to treat hypercholesteremia .it is metabolized by CYP3a4.patients with atherosclerotic disease are frequently treated with clopidogrel and atorvastatin or another
statin.
Pravastatin is administered as monosodium salt and is present in the systemic circulation as the acid form which accounts for 75% of its activity .It undergoes extensive first-pass metabolism by non-CYP3A4mechanisms.So it will not be involved in interactions with drugs metabolized by CYP450. (Michael 1999).so coadministration of pravastatin with clopidogrel did not influence platelet aggregation.
This study was carried out in the coronary care unit, EI-Minia University
Hospital during the period from December 2003 through December 2004.
The purpose of this study to clarify the Influence of Atorvastatin Pravastatin , and Fluvastatin on the ability of Clopidogrel to inhibit platelet aggregation in patients with unstable angina.
To address this issue 60 patients suffering from unstable angina with
platelet count more than 100,000 received aspirin150mg/d and nadroparinNa
In recent years, its physiopathology has been clarified and there have been major advances in management.
Pathological, angioscopic and biological observations have demonstrated that unstable angina and myocardial infarction are different clinical presentations that result from a common underlying pathophysiological mechanism, namely, atherosclerotic plaque rupture or erosion, with differing degrees of superimposed thrombosis and distal embolization.
Clopidogrel inhibits platelet aggregation through binding selectively and noncompetitively to platelet ADP receptor in an irreversible manner preventing activation of glycoprotein lib/lila receptor which mediates the final common pathway of platelet aggregation.
Atorvastatin is a (HMG-CoA) reductase inhibitor widely used to treat hypercholesteremia .it is metabolized by CYP3a4.patients with atherosclerotic disease are frequently treated with clopidogrel and atorvastatin or another
statin.
Pravastatin is administered as monosodium salt and is present in the systemic circulation as the acid form which accounts for 75% of its activity .It undergoes extensive first-pass metabolism by non-CYP3A4mechanisms.So it will not be involved in interactions with drugs metabolized by CYP450. (Michael 1999).so coadministration of pravastatin with clopidogrel did not influence platelet aggregation.
This study was carried out in the coronary care unit, EI-Minia University
Hospital during the period from December 2003 through December 2004.
The purpose of this study to clarify the Influence of Atorvastatin Pravastatin , and Fluvastatin on the ability of Clopidogrel to inhibit platelet aggregation in patients with unstable angina.
To address this issue 60 patients suffering from unstable angina with
platelet count more than 100,000 received aspirin150mg/d and nadroparinNa
Other data
| Title | Influence of different statins on the ability Clopidogrel to inhibit platelet aggregation in patients with unstable angina | Other Titles | تأثير عقارات الستاتين علي قدرة عقار الكلوبيدوجريل علي تثبيط تجمع الصفائح الدموية في مرضي الذبحة الصدرية الغير مستقرة | Authors | Mahmoud Mohamad Shehata | Issue Date | 2005 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| Mahmoud Mohamad Shehata.pdf | 1.58 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.